Nephrology & Urology drugs

44 results

  • acthar

    (Repository Corticotropin)
    Mallinckrodt ARD LLC
    Acthar Gel is indicated for treating infantile spasms in infants under 2, acute exacerbations of multiple sclerosis in adults, and as adjunctive therapy for various rheumatic disorders. It is also used for certain collagen diseases, severe dermatologic and allergic conditions, ophthalmic inflammatory diseases, symptomatic sarcoidosis, and nephrotic syndrome.

  • adstiladrin

    (nadofaragene firadenovec-vncg)
    Ferring Pharmaceuticals
    ADSTILADRIN® is indicated for treating high-risk BCG-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) in adults, specifically for those with carcinoma in situ (CIS) with or without papillary tumors.

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 25 is indicated for emergency treatment of hypovolemic shock, burn therapy, and as a treatment for hypoproteinemia, ARDS, acute liver failure, neonatal hemolytic disease, and acute nephrosis. It may also be used during cardiopulmonary bypass and renal dialysis to maintain blood volume and colloid osmotic pressure.

  • balversa

    (Erdafitinib)
    Janssen Products LP
    BALVERSA is indicated for treating adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with FGFR3 genetic alterations, following progression on at least one prior systemic therapy. Selection of patients must utilize an FDA-approved companion diagnostic. It is not recommended for those eligible for PD-1 or PD-L1 inhibitors.

  • botox

    (onabotulinumtoxinA)
    Allergan, Inc.
    BOTOX is indicated for treating overactive bladder, neurogenic detrusor overactivity in pediatric patients, chronic migraine prophylaxis, spasticity, cervical dystonia, severe primary axillary hyperhidrosis, and blepharospasm/strabismus associated with dystonia in patients aged 12 and older. It is meant for those unresponsive or intolerant to anticholinergic medications.

  • carospir

    (CaroSpir)
    CMP Pharma, Inc.
    CAROSPIR is indicated for the treatment of NYHA Class III-IV heart failure with reduced ejection fraction, hypertension as an add-on therapy, and edema in adult cirrhotic patients unresponsive to fluid and sodium restriction. It aims to improve survival, manage edema, and reduce hospitalization for heart failure.

  • detrol la

    (tolterodine tartrate)
    Viatris Specialty LLC
    DETROL LA Capsules are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency.

  • eligard

    (Leuprolide Acetate)
    TOLMAR Inc.
    ELIGARD® is indicated for the palliative treatment of advanced prostate cancer.

  • entadfi

    (finasteride and tadalafil)
    Veru Inc.
    ENTADFI is indicated for the initiation of treatment for signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks. Use beyond 26 weeks is not recommended due to decreasing benefits.

  • erleada

    (Apalutamide)
    Janssen Products, LP
    ERLEADA is indicated for treating metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC).